FDA Drug recall D-1077-2018
Lisinopril Tablets USP, 10mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals Inc
- FDA Drug
- Class II
- terminated
- Published 2018-08-22
On 2018-08-22 the FDA classified a Class II recall of Lisinopril Tablets USP, 10mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals Inc by Lupin Pharmaceuticals, citing presence of Foreign Substance: Product complaint was received of metal contaminant observed in one tablet.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1077-2018 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2018-08-13 |
| Published | 2018-08-22 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Lupin Pharmaceuticals |
| Distribution | US |
Product
Lisinopril Tablets USP, 10mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals Inc. Baltimore, Maryland 21202, NDC 68180-980-03
Reason
Presence of Foreign Substance: Product complaint was received of metal contaminant observed in one tablet.
Identifiers
| ndc | 68180-512-02 |
|---|---|
| ndc | 68180-512-30 |
| ndc | 68180-512-09 |
| ndc | 68180-512-01 |
| ndc | 68180-512-03 |
| ndc | 68180-513-30 |
| ndc | 68180-513-03 |
| ndc | 68180-513-01 |
| ndc | 68180-513-09 |
| ndc | 68180-513-02 |
| ndc | 68180-513-05 |
| ndc | 68180-517-03 |
| ndc | 68180-517-01 |
| ndc | 68180-517-30 |
| ndc | 68180-517-09 |
| ndc | 68180-517-04 |
| ndc | 68180-517-02 |
| ndc | 68180-980-03 |
| ndc | 68180-980-30 |
| ndc | 68180-980-01 |
| ndc | 68180-980-09 |
| ndc | 68180-980-05 |
| ndc | 68180-980-02 |
| ndc | 68180-981-01 |
| ndc | 68180-981-03 |
| ndc | 68180-981-30 |
| ndc | 68180-981-09 |
| ndc | 68180-981-02 |
| ndc | 68180-981-05 |
| ndc | 68180-982-01 |
| ndc | 68180-982-02 |
| ndc | 68180-982-30 |
| ndc | 68180-982-03 |
| ndc | 68180-982-09 |
| ndc | 68180-979-01 |
| ndc | 68180-979-03 |
| ndc | 68180-979-30 |
| ndc | 68180-979-09 |
| ndc | 68180-514-01 |
| ndc | 68180-514-02 |
| ndc | 68180-514-03 |
| ndc | 68180-514-09 |
| ndc | 68180-514-30 |
| ndc | 68180-514-05 |
| ndc | 68180-515-01 |
| ndc | 68180-515-02 |
| ndc | 68180-515-03 |
| ndc | 68180-515-09 |
| ndc | 68180-515-30 |
| ndc | 68180-515-05 |
| ndc | 68180-516-01 |
| ndc | 68180-516-02 |
| ndc | 68180-516-03 |
| ndc | 68180-516-09 |
| ndc | 68180-516-30 |
| code_info | Lot #: H800414, Exp. 12/2019 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1077-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.